U.S. National Institute of Health www.cancer.gov National Cancer Institute
National Cancer Institute
Skip Header Navigation
Skip Navigation

Agenda

Meeting Objectives

Overall: the NCI's goal in these think tanks is to explore research opportunities at the intersection of the physical sciences and cancer biology that will enable a deeper understanding of cancer and inform the development of better approaches to detect, treat and prevent this complex disease.

  • From the perspective of both the physical and biological sciences - to determine the "state of the science" of evolution and evolutionary theory in terms of our current understanding of cancer at all scales.
  • To explore the relationships between current areas of intense focus in cancer research, e.g., genomics, proteomics, molecularly based drug discovery and development, etc., in terms of the role of evolution and evolutionary theory in oncology at all scales.
  • To identify critical questions in cancer evolution that if addressed will enhance our understanding of cancer development and outcomes.
  • For this think tank, to offer guidance on how through leadership, utilization of existing and new research support mechanisms, etc. the NCI can best engage broader communities of physical and biomedical scientist to address key questions in cancer evolution and evolutionary theory applied to cancer.

Outcomes

The conversations that comprise this think tank, including brainstorming sessions, presentations, roundtables and reports from work groups will be captured in a report - and available on an NCI website dedicated to this Physical-Sciences and Frontiers in Oncology Series. In addition, input from the meeting will be utilized to inform new research directions and mechanisms that will hopefully energize and advance this critical field.

Funding Opportunities
Find out more about funding opportunities available in physical sciences. More
Purple border
News & Events
Read the latest on Physical Sciences in Oncology and related activities. More
Agenda

Sunday, July 13
5:00 p.m. - 6:00 p.m. Registration
6:00 p.m. - 7:15 p.m. Reception and Buffet Dinner Salon II
7:30 p.m. - 7:50 p.m. Background for the Meeting
Anna D. Barker, Ph.D.
Deputy Director
National Cancer Institute

Welcome and Introduction of Keynote Presentation
John E. Niederhuber, M.D.
Director
National Cancer Institute
Salon I
7:50 p.m. - 8:50 p.m. Keynote Presentation
The Causes and Prevention of Cancer: Can an Evolutionary Perspective Allow Us to See the Forest and the Trees?
Paul W. Ewald, Ph.D.
Professor and Director, Program on Disease Evolution
University of Louisville
  Questions and Discussion
8:50 p.m. - 9:00 p.m. Think Tank Process Introductions
Anna D. Barker, Ph.D.
Deputy Director
National Cancer Institute
9:00 p.m. - 9:15 p.m. Expectations
Facilitator: Robert J. Mittman, M.S., M.P.P.
Founder/President
Facilitation, Foresight, Strategy
Meeting Facilitator
Monday, July 14
7:00 a.m. - 8:00 a.m. Continental Breakfast
8:00 a.m. - 8:30 a.m.

Welcome
John E. Niederhuber, M.D.
Director
National Cancer Institute

Background for Today's Think Tank
Anna D. Barker, Ph.D.
Deputy Director
National Cancer Institute

Salons I
  Process and Flow for the Think Tank
Facilitator: Robert J. Mittman, M.S., M.P.P.
Founder/President
Facilitation, Foresight, Strategy
Introduction-Keynote Presentation
8:30 a.m. - 10:00 a.m. Evolution and Evolutionary Theory in Cancer; Status of the Field
An Environmental Scan
Group Discussion
Facilitator: Robert J. Mittman, M.S., M.P.P.
Founder/President
Facilitation, Foresight, Strategy
Meeting Facilitator
10:00 a.m. - 10:15 a.m. Break
10:15 a.m. - 10:45 a.m. Keynote Presentation
Evolution and Cancer: Through the Eyes of a Physicist
Robert H. Austin, Ph.D.
Department of Physics
Princeton University
10:45 a.m. - 11:15 a.m. Keynote Presentation
Evolution and Cancer: A Biologist View of the State of the Science
Carlo C. Maley, Ph.D.
Assistant Professor
The Wistar Institute
11:15 a.m. - 12:30 p.m. Group Discussions
Evolution and Evolutionary Theory: What are the Critical Questions and/or Barriers?

Facilitator: Robert J. Mittman, M.S., M.P.P.
Founder/President
Facilitation, Foresight, Strategy
12:30 p.m. - 1:35 p.m. Lunch
1:30 p.m. - 3:00 p.m.

Roundtable Discussion: Exploration of these and Other Critical Questions/Barriers Surrounding Evolution, Evolutionary Theory and Cancer

Roundtable Participants

Paul Davies, Ph.D.
Professor and Director
Beyond Institute

Donald S. Coffey, Ph.D.
Distinguished Professor of Urology
Johns Hopkins University

Raju Kucherlapati, Ph.D.
Scientific Director
Harvard Partners Center for Genetics and Genomics

Brian J. Reid, M.D., Ph.D.
Member, Fred Hutchinson Cancer Research Center
Professor of Medicine, University of Washington

3:00 p.m. - 3:15 p.m. Break
3:15 p.m. - 5:15 p.m.

Evolution and Evolutionary Theory in Cancer - Addressing the Critical Questions (An Integrated Group Conversation)

Group Discussions
Individual Group Facilitation and Reporting
Facilitator: Robert J. Mittman, M.S., M.P.P.
Founder/President
Facilitation, Foresight, Strategy
5:15 p.m. - 5:45 p.m. Quick Hit (Headlines) Report From the Groups
Facilitator: Robert J. Mittman, M.S., M.P.P.
Founder/President
Facilitation, Foresight, Strategy

Plan for Tomorrow

6:30 p.m. Reception and Dinner

Foyer Salon I

Tuesday, July 15
7:00 a.m. - 8:00 a.m. Continental Breakfast
8:00 a.m. - 8:15 a.m. Review of Day 1
Facilitator: Robert J. Mittman, M.S., M.P.P.
Founder/President
Facilitation, Foresight, Strategy
Salon I
8:15 a.m. - 8:45 a.m. Keynote Presentation
Breast Cancer: Would Evolutionary Thinking Change Our Understanding and Management of this Complex Disease?
Larry Norton, M.D.
Deputy Physician-in-Chief for Breast Cancer Programs
Memorial Sloan-Kettering Cancer Center
8:45 a.m. - 10:15 a.m.

Panel: Research and Commentary - Cancer in the Context of Evolution
(Cancer as Viewed by Evolutionists; Development of Interventions - What Could Change? Modeling in the Context of Evolution)

Cell Lineages - Mutations - and "Predisposition" to Cancer
Steven A. Frank, Ph.D.
Professor
University of California at Irvine

Dynamics of Multilevel Selection and Cancer
John W. Pepper, Ph.D.
Assistant Professor
University of Arizona

Applying Evolutionary Principles and Theory to the Development of Interventions for Cancer
Kenneth J. Pienta, M.D.
Professor
The University of Michigan

Evolution and New Models for Cancer Development and Progression: What Will It Take to Inform the Models?
Thomas S. Deisboeck, M.D.
Assistant Professor
Harvard-MIT (Massachussetts General Hospital)

Questions/Discussion

10:15 a.m. - 10:30 a.m. Break
10:30 a.m. - 1:30 p.m. Converging on the Key Areas of Focus*
Group Discussions - Concept Development Groups Input and Recommendations Salon I, Attaché and Ambassador
 

Working Lunch

Concept work groups continue and prepare to report out

1:30 p.m. - 2:45 p.m. Report Outs: Group Consensus Input - Report Format and Direction and Timing Salon I
2:45 p.m. - 3:00 p.m.

Summary and Next Steps
John E. Niederhuber, M.D.
Director
National Cancer Institute

Anna D. Barker, Ph.D.
Deputy Director
National Cancer Institute

* Converging on the Key Areas for Focus (Major Questions in the Field; Scientific Focus Areas; Key Steps Needed to Enable Progress in the Field; Resource Needs (teams needed; most appropriate mechanistic approaches; and other suggestions as appropriate). Beyond graphic summary, develop outline for section of the meeting report.

 

Skip Footer Navigation